Bayer, Kloeckner, MAN, Rhoen-Klinikum: German Equity Preview
February 08, 2010, 2:13 AM ESTBy Jana Randow and Francesca Cinelli
Feb. 8 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in Germany. Stock symbols are in parentheses and share prices are from the previous close.
The benchmark DAX Index fell 1.8 percent to 5,434.34 on Feb. 5.
Aixtron AG (AIXA GY): HSBC Holdings Plc initiated coverage of the maker of specialized equipment used to produce LED screens with an “overweight” recommendation. The shares dropped 6.5 percent to 20.34 euros.
Bayer AG (BAYN GY): Chief Executive Officer Werner Wenning said acquisitions are part of the company’s goal to expand its business, the newspaper Frankfurter Allgemeine Sonntagszeitung reported. The shares fell 3.2 percent to 46.82 euros.
Dyckerhoff AG (DYK3 GY): The German cement maker majority- owned by Buzzi Unicem SpA releases preliminary fourth-quarter numbers. The shares rose 0.7 percent to 46.05 euros.
Infineon Technologies AG (IFX GY): Barclays Capital lifted its price estimate on Europe’s second-largest chipmaker to 5 euros from 3.6 euros. The brokerage reiterated an “overweight” recommendation. The shares fell 3.7 percent to 3.96 euros.
Kloeckner & Co. SE (KCO GY): Chief Executive Officer Gisbert Ruehl said steel companies will probably run into difficulties when looking for credit in the coming months, the newspaper Euro am Sonntag reported, citing an interview. The shares plunged 6.8 percent to 16.38 euros.
MAN SE (MAN GY): Chief Executive Officer Georg Pachta- Reyhofen said he expects orders to recover in the second half of the year, Germany’s Sueddeutsche Zeitung reported. The shares fell 0.8 percent to 50.18 euros.
Rhoen-Klinikum AG (RHK GY): Chief Financial Officer Erik Hamann said the hospital operator is “only at the beginning” of an acquisition streak, Boersen-Zeitung reported, citing an interview. The shares dropped 1.5 percent to 17.54 euros.
Stratec Biomedical Systems AG (SBS GY): The company expects sales to increase by 30 percent this year and by an average of more than 15 percent between 2010 and 2012, Chief Financial Officer Marcus Wolfinger told Boersen-Zeitung. The shares slid 0.9 percent to 26.25 euros.
--Editors: John Simpson, David Merritt.
To contact the reporters on this story: Jana Randow in Frankfurt at jrandow@bloomberg.net. Francesca Cinelli in Milan at fcinelli@bloomberg.net
To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net
